Logo image of NCLH

NORWEGIAN CRUISE LINE HOLDIN (NCLH) Stock Fundamental Analysis

NYSE:NCLH - New York Stock Exchange, Inc. - BMG667211046 - Common Stock - Currency: USD

17.67  +0.02 (+0.11%)

After market: 17.68 +0.01 (+0.06%)

Fundamental Rating

3

NCLH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 133 industry peers in the Hotels, Restaurants & Leisure industry. While NCLH is still in line with the averages on profitability rating, there are concerns on its financial health. NCLH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NCLH was profitable.
In the past year NCLH had a positive cash flow from operations.
In multiple years NCLH reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: NCLH reported negative operating cash flow in multiple years.
NCLH Yearly Net Income VS EBIT VS OCF VS FCFNCLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

With a decent Return On Assets value of 3.99%, NCLH is doing good in the industry, outperforming 63.16% of the companies in the same industry.
NCLH has a Return On Equity of 60.19%. This is amongst the best in the industry. NCLH outperforms 96.24% of its industry peers.
The Return On Invested Capital of NCLH (7.50%) is better than 63.16% of its industry peers.
Industry RankSector Rank
ROA 3.99%
ROE 60.19%
ROIC 7.5%
ROA(3y)-2.27%
ROA(5y)-10.54%
ROE(3y)-1056.87%
ROE(5y)-689.6%
ROIC(3y)N/A
ROIC(5y)N/A
NCLH Yearly ROA, ROE, ROICNCLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

Looking at the Profit Margin, with a value of 9.05%, NCLH is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
NCLH's Profit Margin has declined in the last couple of years.
NCLH's Operating Margin of 15.38% is fine compared to the rest of the industry. NCLH outperforms 69.17% of its industry peers.
NCLH's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 40.47%, NCLH is not doing good in the industry: 62.41% of the companies in the same industry are doing better.
NCLH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.38%
PM (TTM) 9.05%
GM 40.47%
OM growth 3YN/A
OM growth 5Y-3.24%
PM growth 3YN/A
PM growth 5Y-7.78%
GM growth 3YN/A
GM growth 5Y-1.58%
NCLH Yearly Profit, Operating, Gross MarginsNCLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

0

2. Health

2.1 Basic Checks

NCLH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for NCLH has been increased compared to 1 year ago.
Compared to 5 years ago, NCLH has more shares outstanding
NCLH has a better debt/assets ratio than last year.
NCLH Yearly Shares OutstandingNCLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
NCLH Yearly Total Debt VS Total AssetsNCLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

NCLH has an Altman-Z score of 0.23. This is a bad value and indicates that NCLH is not financially healthy and even has some risk of bankruptcy.
NCLH has a Altman-Z score of 0.23. This is amonst the worse of the industry: NCLH underperforms 82.71% of its industry peers.
NCLH has a Debt/Equity ratio of 9.09. This is a high value indicating a heavy dependency on external financing.
NCLH has a worse Debt to Equity ratio (9.09) than 65.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 9.09
Debt/FCF N/A
Altman-Z 0.23
ROIC/WACC0.87
WACC8.65%
NCLH Yearly LT Debt VS Equity VS FCFNCLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

NCLH has a Current Ratio of 0.19. This is a bad value and indicates that NCLH is not financially healthy enough and could expect problems in meeting its short term obligations.
NCLH has a worse Current ratio (0.19) than 96.99% of its industry peers.
A Quick Ratio of 0.16 indicates that NCLH may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.16, NCLH is doing worse than 95.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.16
NCLH Yearly Current Assets VS Current LiabilitesNCLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 65.38% over the past year.
NCLH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.68% yearly.
Looking at the last year, NCLH shows a small growth in Revenue. The Revenue has grown by 5.57% in the last year.
Measured over the past years, NCLH shows a small growth in Revenue. The Revenue has been growing by 7.96% on average per year.
EPS 1Y (TTM)65.38%
EPS 3YN/A
EPS 5Y-18.68%
EPS Q2Q%-56.25%
Revenue 1Y (TTM)5.57%
Revenue growth 3Y144.57%
Revenue growth 5Y7.96%
Sales Q2Q%-2.91%

3.2 Future

Based on estimates for the next years, NCLH will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.66% on average per year.
Based on estimates for the next years, NCLH will show a quite strong growth in Revenue. The Revenue will grow by 9.07% on average per year.
EPS Next Y14.88%
EPS Next 2Y18.27%
EPS Next 3Y17.99%
EPS Next 5Y18.66%
Revenue Next Year6.55%
Revenue Next 2Y8.13%
Revenue Next 3Y8.31%
Revenue Next 5Y9.07%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NCLH Yearly Revenue VS EstimatesNCLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
NCLH Yearly EPS VS EstimatesNCLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.27 indicates a reasonable valuation of NCLH.
Based on the Price/Earnings ratio, NCLH is valued cheaply inside the industry as 93.23% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.29. NCLH is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 6.98, the valuation of NCLH can be described as very cheap.
Based on the Price/Forward Earnings ratio, NCLH is valued cheaper than 93.23% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.17. NCLH is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.27
Fwd PE 6.98
NCLH Price Earnings VS Forward Price EarningsNCLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

NCLH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NCLH is cheaper than 73.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.94
NCLH Per share dataNCLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NCLH's earnings are expected to grow with 17.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y18.27%
EPS Next 3Y17.99%

0

5. Dividend

5.1 Amount

NCLH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NORWEGIAN CRUISE LINE HOLDIN

NYSE:NCLH (6/2/2025, 6:30:00 PM)

After market: 17.68 +0.01 (+0.06%)

17.67

+0.02 (+0.11%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners80.67%
Inst Owner Change2.34%
Ins Owners0.39%
Ins Owner Change2.57%
Market Cap7.90B
Analysts81.25
Price Target25.74 (45.67%)
Short Float %6.79%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)58.89%
Min EPS beat(2)-24.41%
Max EPS beat(2)142.19%
EPS beat(4)3
Avg EPS beat(4)33.38%
Min EPS beat(4)-24.41%
Max EPS beat(4)142.19%
EPS beat(8)6
Avg EPS beat(8)20.04%
EPS beat(12)8
Avg EPS beat(12)12.42%
EPS beat(16)9
Avg EPS beat(16)7.19%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-2.76%
Max Revenue beat(2)-1.75%
Revenue beat(4)0
Avg Revenue beat(4)-1.9%
Min Revenue beat(4)-2.76%
Max Revenue beat(4)-0.69%
Revenue beat(8)0
Avg Revenue beat(8)-1.88%
Revenue beat(12)1
Avg Revenue beat(12)-1.79%
Revenue beat(16)1
Avg Revenue beat(16)-9.37%
PT rev (1m)-8.7%
PT rev (3m)-14.75%
EPS NQ rev (1m)-1.78%
EPS NQ rev (3m)-5.94%
EPS NY rev (1m)-1.49%
EPS NY rev (3m)-2.12%
Revenue NQ rev (1m)-1.06%
Revenue NQ rev (3m)-1.92%
Revenue NY rev (1m)-0.65%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE 10.27
Fwd PE 6.98
P/S 0.84
P/FCF N/A
P/OCF 4.11
P/B 5.57
P/tB 10.12
EV/EBITDA 8.94
EPS(TTM)1.72
EY9.73%
EPS(NY)2.53
Fwd EY14.33%
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)4.3
OCFY24.34%
SpS21.07
BVpS3.17
TBVpS1.75
PEG (NY)0.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 60.19%
ROCE 9.49%
ROIC 7.5%
ROICexc 7.59%
ROICexgc 7.92%
OM 15.38%
PM (TTM) 9.05%
GM 40.47%
FCFM N/A
ROA(3y)-2.27%
ROA(5y)-10.54%
ROE(3y)-1056.87%
ROE(5y)-689.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-0.2%
ROICexc growth 3YN/A
ROICexc growth 5Y2.69%
OM growth 3YN/A
OM growth 5Y-3.24%
PM growth 3YN/A
PM growth 5Y-7.78%
GM growth 3YN/A
GM growth 5Y-1.58%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 9.09
Debt/FCF N/A
Debt/EBITDA 5.3
Cap/Depr 253.06%
Cap/Sales 26.31%
Interest Coverage 250
Cash Conversion 79.17%
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.16
Altman-Z 0.23
F-Score7
WACC8.65%
ROIC/WACC0.87
Cap/Depr(3y)218.66%
Cap/Depr(5y)176.64%
Cap/Sales(3y)27.26%
Cap/Sales(5y)54.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.38%
EPS 3YN/A
EPS 5Y-18.68%
EPS Q2Q%-56.25%
EPS Next Y14.88%
EPS Next 2Y18.27%
EPS Next 3Y17.99%
EPS Next 5Y18.66%
Revenue 1Y (TTM)5.57%
Revenue growth 3Y144.57%
Revenue growth 5Y7.96%
Sales Q2Q%-2.91%
Revenue Next Year6.55%
Revenue Next 2Y8.13%
Revenue Next 3Y8.31%
Revenue Next 5Y9.07%
EBIT growth 1Y27.22%
EBIT growth 3YN/A
EBIT growth 5Y4.47%
EBIT Next Year79.91%
EBIT Next 3Y30.5%
EBIT Next 5Y21.75%
FCF growth 1Y28.05%
FCF growth 3YN/A
FCF growth 5Y35.24%
OCF growth 1Y77.25%
OCF growth 3YN/A
OCF growth 5Y2.38%